Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR — TI-PAD EVR

Peripheral Artery Disease (PAD) Clinical Trial

Official title:
A Phase II Multicentre, Randomised, Double-Blind, Controlled, Parallel-Group Study to Evaluate the Walking Time Effect of Long-Term Ticagrelor in Comparison to Long-Term Aspirin Administration in Ambulatory Patients With Peripheral Artery Disease Undergoing Endovascular Revascularization - The Ticagrelor in Peripheral Artery Disease Endovascular Revascularization Study TI-PAD I EVR

Status Terminated

Clinical Trial Summary

To compare the effect of ticagrelor versus aspirin on the change in peak walking time, evaluated on the graded treadmill test, from one to 26 weeks post-revascularization in patients with peripheral artery disease who have undergone endovascular revascularization for moderate to severe claudication or ischemic rest pain.

Clinical Trial Description

A Phase II Multicentre, Randomised, Double-Blind, Controlled, Parallel-Group Study to Evaluate the Walking Time Effect of Long-Term Ticagrelor in Comparison to Long-Term Aspirin Administration in Ambulatory Patients with Peripheral Artery Disease Undergoing Endovascular Revascularization - The Ticagrelor in Peripheral Artery Disease Endovascular Revascularization Study TI-PAD I EVR ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02227368
Study type	Interventional
Source	AstraZeneca
Contact
Status	Terminated
Phase	Phase 2
Start date	October 2014
Completion date	May 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03744572` - Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions
Recruiting	`NCT06052319` - A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
Recruiting	`NCT05941533` - Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease
Active, not recruiting	`NCT02924857` - The Chocolate Touch Study	N/A
Not yet recruiting	`NCT05665816` - Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent
Active, not recruiting	`NCT04821388` - Α Pre CE-Marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries	N/A
Recruiting	`NCT03304821` - Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease	Phase 2
Completed	`NCT02220686` - Vascular Physician Offer and Report (VAPOR) Trial	N/A